Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: A phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male japanese subjects

✍ Scribed by Akiko Sarashina; Shogo Sesoko; Mitsuyoshi Nakashima; Naoyuki Hayashi; Atsushi Taniguchi; Yoshiharu Horie; Eva U. Graefe-Mody; Hans-Juergen Woerle; Klaus A. Dugi

• Book ID: 113544238
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 212 KB
• Volume: 32
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2010.06.004